Impact of chronic ethanol consumption and SARS ‐ COV ‐2 on the liver and intestine: A pilot dose–response study in mice
Alcohol, Clinical and Experimental Research · 2025
DOI: 10.1111/acer.15528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, 2025. Verfasst von Smita Ghare und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky, …. Hauptthemen laut MEDLINE: COVID-19, Liver, Ethanol, SARS-CoV-2. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Background
During the coronavirus disease 2019 (COVID‐19) pandemic, there was a marked increase in alcohol consumption. COVID‐19 superimposed on underlying liver disease notably worsens the outcome of many forms of liver injury. The goal of a current pilot study was to test the dual exposure of alcohol and COVID‐19 infection in an experimental animal model of alcohol‐associated liver disease (ALD).
Methods
After 4 weeks of ethanol (EtOH) feeding, C57BL/6 male mice received SARS‐CoV‐2 (SARS2‐N501Y MA30 ) intranasally at 3 × 10 2 , 1 × 10 3 , 3 × 10 3 , and 1 × 10 4 plaque‐forming units (PFU). Mice were then weighed/monitored daily for morbidity/mortality for 10 days while continuing EtOH consumption. Markers of liver inflammation, injury, and intestinal barrier integrity were evaluated.
Results
A similar gradual weight loss was observed in all inoculated mice (slightly less in the 3 × 10 2 group) up to post‐infection day 4. Greater mortality was observed in mice receiving the highest viral dose at days 3 and 4 post‐infection. The majority of the surviving mice subjected to EtOH and inoculated with 3 × 10 3 or 1 × 10 4 PFU rapidly lost 25% of their body weight and were euthanized on post‐infection day 4. Analysis of liver health in animals that survived to the end of the experiment exhibited no significant changes in hepatic steatosis but had a limited increase in plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels at all viral doses versus EtOH alone. However, the 1 × 10 4 PFU viral dose exacerbated EtOH‐induced hepatic inflammation characterized by elevated levels of several pro‐inflammatory cytokines, including Il‐6 and Tnf‐α . There was limited effect of viral infection on the intestine.
Conclusions
SARS‐CoV‐2 infection caused a dose‐dependent negative impact on body weight and survival in mice fed EtOH. This pilot study suggests that early mortality observed after high‐dose SARS‐CoV‐2 challenge could be due, in part, to hepatic dysfunction following chronic EtOH feeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
- Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
- Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, Kentucky, USA.
- Department of Structural & Cellular Biology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
- Department of Pathology, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
- Alcohol Research Center, University of Louisville, Louisville, Kentucky, USA.
ORCID-Profile: Paula M Chilton, Craig McClain, Irina Kirpich
Förderung
- NIAAA NIH HHS
- NIH HHS
- NIGMS NIH HHS
- U.S. Department of Veterans Affairs
- BLRD VA
- CSRD VA
- National Institutes of Health
Zitieren
APA
Ghare, S., Warner, D., Warner, J., Chilton, P. M., Lee, J., Zhang, J., Wang, M., Hardesty, J., Treves, R., Gabbard, J., Anderson, C., Batra, L., Sreenivasan, C., Kraenzle, J., McCulley, M., McCoy, S., Zhang, L., Feng, W., Gondim, D. D., …, & Kirpich, I. (2025). Impact of chronic ethanol consumption and SARS ‐ COV ‐2 on the liver and intestine: A pilot dose–response study in mice. Alcohol, Clinical and Experimental Research. https://doi.org/10.1111/acer.15528
Vancouver
Ghare S, Warner D, Warner J, Chilton PM, Lee J, Zhang J, et al. Impact of chronic ethanol consumption and SARS ‐ COV ‐2 on the liver and intestine: A pilot dose–response study in mice. Alcohol, Clinical and Experimental Research. 2025. doi:10.1111/acer.15528
BibTeX
@article{Ghare2025,
author = {Ghare, Smita and Warner, Dennis and Warner, Jeffrey and Chilton, Paula M and Lee, Jiyeon and Zhang, JingWen and Wang, Min and Hardesty, Josiah and Treves, Rui and Gabbard, Jon and Anderson, Charles and Batra, Lalit and Sreenivasan, Chithra and Kraenzle, Jennifer and McCulley, Matthew and McCoy, Stephanie and Zhang, Lihua and Feng, Wenke and Gondim, Dibson Dibe and Barve, Shirish and Zheng, Jian and Palmer, Kenneth and McClain, Craig and Kirpich, Irina},
title = {Impact of chronic ethanol consumption and SARS ‐ COV ‐2 on the liver and intestine: A pilot dose–response study in mice},
journal = {Alcohol, Clinical and Experimental Research},
year = {2025},
doi = {10.1111/acer.15528}
}
EUVIMED